Jefferies Raises COV Target To $56 From $52

January 27, 2011 7:13 AM | 5 seconds read |
Jefferies is raising its PT on Covidien COV $56 from $52.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Analyst RatingsCovidienHealth CareHealth Care EquipmentJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!